Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingfang Zhang

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Channels (Austin, Tex.)|May 3, 2023
Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinomaFangyu Chai, Jingfang Zhang, Tao Fu, et al.
Blood|May 21, 2013
Nras(G12D/+) promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functionsJinyong Wang, Guangyao Kong, Yangang Liu, et al.
British Journal of Haematology|April 5, 2014
Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutationYuan-I Chang, Alisa Damnernsawad, Laura K Allen, et al.
The Journal of Clinical Investigation|May 10, 2014
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasmGuangyao Kong, Mark Wunderlich, David Yang, et al.
Leukemia|September 13, 2018
Downregulating Notch counteracts KrasGuangyao Kong, Xiaona You, Zhi Wen, et al.
Blood|November 6, 2016
p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemiaJingfang Zhang, Guangyao Kong, Adhithi Rajagopalan, et al.
Cell|February 21, 2012
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastasesZhihu Ding, Chang-Jiun Wu, Mariela Jaskelioff, et al.
Nature Communications|January 9, 2020
Modulation of brain cation-Cl<sup>-</sup> cotransport via the SPAK kinase inhibitor ZT-1aJinwei Zhang, Mohammad Iqbal H Bhuiyan, Ting Zhang, et al.
EMBO Molecular Medicine|November 30, 2021
A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLCYue Lu, Zhenzhen Fan, Su-Jie Zhu, et al.
Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Channels (Austin, Tex.)|May 3, 2023
Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinomaFangyu Chai, Jingfang Zhang, Tao Fu, et al.
Blood|May 21, 2013
Nras(G12D/+) promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functionsJinyong Wang, Guangyao Kong, Yangang Liu, et al.
British Journal of Haematology|April 5, 2014
Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutationYuan-I Chang, Alisa Damnernsawad, Laura K Allen, et al.
The Journal of Clinical Investigation|May 10, 2014
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasmGuangyao Kong, Mark Wunderlich, David Yang, et al.
Leukemia|September 13, 2018
Downregulating Notch counteracts KrasGuangyao Kong, Xiaona You, Zhi Wen, et al.
Blood|November 6, 2016
p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemiaJingfang Zhang, Guangyao Kong, Adhithi Rajagopalan, et al.
Cell|February 21, 2012
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastasesZhihu Ding, Chang-Jiun Wu, Mariela Jaskelioff, et al.
Nature Communications|January 9, 2020
Modulation of brain cation-Cl<sup>-</sup> cotransport via the SPAK kinase inhibitor ZT-1aJinwei Zhang, Mohammad Iqbal H Bhuiyan, Ting Zhang, et al.
EMBO Molecular Medicine|November 30, 2021
A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLCYue Lu, Zhenzhen Fan, Su-Jie Zhu, et al.
Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
Pageof 9